IFNA1 and COVID-19: Likewise, patients with genetic variants of genes related to IFN-α response or carrying anti-IFN-α antibodies display a severe outcome of COVID-19, suggesting a primary role of IFN-α in controlling SARS-CoV-2 infection (42, 43).